refludan and Liver-Diseases

refludan has been researched along with Liver-Diseases* in 1 studies

Other Studies

1 other study(ies) available for refludan and Liver-Diseases

ArticleYear
[Heparin-induced thrombocytopenia and liver hemorrhage following polytrauma].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2009, Volume: 80, Issue:9

    Up to 3% of patients receiving unfractioned heparin develop heparin-induced thrombocytopenia (HIT). We report on a polytrauma patient who developed severe HIT with bilateral pulmonary embolism. Lepirudin treatment resulted initially in rapid improvement. Ten days after discharge the patient complained of abdominal pain. A large subcapsular hepatic hematoma was diagnosed, requiring repeat surgery and ending in secondary sclerosing cholangitis. This process can potentially be avoided by regular tests of lepirudin concentration and coagulation.

    Topics: Anticoagulants; Aortic Rupture; Blood Coagulation Tests; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Female; Heparin; Hernia, Diaphragmatic, Traumatic; Hirudins; Humans; Liver; Liver Diseases; Middle Aged; Multiple Trauma; Patient Readmission; Platelet Count; Postoperative Complications; Postoperative Hemorrhage; Recombinant Proteins; Reoperation; Thrombocytopenia; Tomography, X-Ray Computed

2009